How HRGs, tariffs, OPCS coding and clinical data science quietly determine how UK hospitals are funded and why this machinery shapes every diagnosis, procedure and financial decision across the NHS.

The hidden science of HRGs, tariffs, OPCS coding and the financial machinery that funds UK healthcare.. Behind every consultation, operation, or diagnostic test delivered within the NHS lies an intricate system of data, algorithms, and economic logic that silently determines how hospitals are paid. This hidden machinery—built on Healthcare Resource Groups (HRGs), OPCS-4 procedure codes, ICD-10 diagnoses, and the National Tariff—converts clinical activity into financial value. It is one of the most complex and consequential scientific frameworks in modern healthcare economics.

In England, this system is formalised through Payment by Results (PbR) — a national mechanism designed to reward hospitals for the volume and complexity of care they provide. Each patient episode is grouped by the NHS Digital HRG Grouper, which analyses diagnostic and procedural codes to create a standardised “currency” for healthcare. These HRGs, combined with weighting factors derived from detailed cost data, form the basis of the tariff prices paid through the NHS Payment Scheme.

Across the devolved nations, however, the landscape diverges. Scotland, Wales, and Northern Ireland retain a more hybrid or block-contract funding model, often blending activity-based payments with local budgets. Yet even there, the scientific backbone of HRG methodology and OPCS coding quietly informs cost benchmarking, performance reporting, and service planning — proof that the “coding genome” of the NHS remains deeply embedded throughout the UK.

This article explores the science, policy, and reality behind the NHS reimbursement engine:

how HRGs are designed, weighted, and updated;
who governs the system and how it adapts to new technologies;
where the framework succeeds in driving efficiency and fairness; and
where distortions such as “HRG drift” and data inconsistencies threaten its integrity.

To decode the NHS is to understand its financial DNA, a living system where clinical precision meets economic modelling and where coding accuracy can influence not just hospital budgets but the adoption of innovation itself.

England serves as the hub for HRG and tariff science.

The Origins: How England Engineered a Data-Driven Payment System

The English National Health Service pioneered a move from block budgets to activity-based funding in the early 2000s. Prior to that, hospitals received global allocations largely based on historical expenditure and local negotiations, often unrelated to clinical activity. In 2004, the Department of Health launched Payment by Results (PbR)—a revolutionary model in which hospitals would be paid for the number and type of treatments actually delivered.

The foundation of PbR was the Healthcare Resource Group (HRG)—a scientifically constructed unit of care, analogous to the Diagnosis-Related Group (DRG) systems used in the United States and parts of Europe. Each HRG represented a cluster of clinically similar treatments expected to consume comparable levels of NHS resources.

This shift was underpinned by two major drivers:

Transparency: Linking clinical data to financial flows allowed policymakers to identify true costs and reduce arbitrary variation.
Efficiency: Standardised tariffs incentivised hospitals to increase productivity while maintaining quality since excess costs could no longer be disguised within fixed block grants.

From 2004 onwards, successive iterations of the National Tariff formalised this science of payment, converting HRGs into specific prices per episode of care.

The Science of HRGs: Turning Codes into Currency

Every patient admitted to an NHS hospital generates a digital trail — diagnoses coded in ICD-10 and procedures in OPCS-4. These data pass through NHS Digital’s Grouper software, which algorithmically assigns an HRG to each episode. The Grouper evaluates variables such as age, comorbidities, length of stay, and procedural hierarchy to determine the most resource-intensive component of care.

Each HRG carries a relative resource weight, derived from the Reference Costs Collection — an annual dataset in which every NHS provider submits real cost data for every HRG they deliver. These weights are multiplied by a national base price to produce the tariff. The process is meticulously managed by the National Casemix Office (NCO) and the Department of Health and Social Care (DHSC), ensuring that cost weights reflect genuine clinical complexity rather than arbitrary financial pressure.

For example:

A simple appendectomy might group to FZ18A, costing a few hundred pounds;
A complex cardiac bypass could group to EA31Z, exceeding £10 000 once all unbundled components are added.

This granular, algorithmic structure turns raw clinical data into the financial DNA of the NHS — a precise map of where money follows medicine.

Governance and Updating: Who Maintains the Machinery

Responsibility for HRG design and maintenance sits with the National Casemix Office, part of NHS England. Each year, the NCO publishes updates that align the Grouper with:

New clinical classifications (ICD-10 and OPCS-4 revisions),
Changes in clinical practice (e.g., robotic surgery, endovascular interventions),
Costing updates from the latest National Cost Collection, and
Policy reforms announced through the NHS Payment Scheme.

These updates ensure that the HRG framework evolves alongside medicine. For instance, the transition from OPCS-4.10 to OPCS-4.11 in 2026 introduces 65 new categories and more than 570 new sub-categories, capturing emerging technologies from image-guided interventions to AI-enabled diagnostics.

NHS England and the DHSC then publish tariffs annually in the National Tariff Payment System (NTPS) or its successor, the NHS Payment Scheme. Each update recalibrates base prices and introduces adjustments for regional cost differences (the Market Forces Factor) and best-practice incentives.

Why It Works — and Why It Sometimes Doesn’t

At its best, the HRG-tariff architecture brings economic rationality to clinical reality. Hospitals performing more or higher-complexity procedures receive commensurate funding, encouraging throughput, cost control, and transparency. The system has improved cost accounting, reduced unexplained regional variation, and allowed robust benchmarking across trusts.

Yet this same precision invites vulnerability. The phenomenon of “HRG drift”, as identified in early BMJ analyses (Rogers et al., 2005), showed how hospitals could unintentionally—or strategically—code patients into higher-paying HRGs. Small shifts in coding practice can translate into millions of pounds in additional reimbursement. Regular audits, Grouper validation, and clinical-coding education remain essential to preserving integrity.

Furthermore, unbundled HRGs, such as diagnostics, chemotherapy cycles, or critical-care stays, complicate accounting and sometimes disconnect reimbursement from real workflow. When tariffs lag behind innovation, novel diagnostics or digital technologies may struggle to detect a matching HRG, delaying uptake despite proven clinical benefit.

The Evolution of Payment by Results: From Tariffs to Schemes

Since 2019, Payment by Results has evolved into the broader NHS Payment Scheme, introducing blended payments that combine fixed and variable components. This recognises that not all healthcare can or should be driven by volume alone — for example, mental-health services, community care, or virtual wards.

Nevertheless, the HRG framework remains the backbone of NHS payment science. It continues to inform everything from hospital budgets and public health analytics to national cost-effectiveness assessments by NICE and NHS Improvement.

In short, the HRG system in England represents one of the most sophisticated implementations of applied health economics anywhere in the world—a living experiment where data science, clinical coding, and fiscal policy merge to sustain the world’s largest publicly funded health service.

Do They Still Use “Payment by Results” (PbR) in England?

The short answer: not anymore—at least not by name.

When the Payment by Results (PbR) framework was launched in 2003–2004, it marked a revolution in NHS funding. For the first time, hospitals were paid per episode of care, with reimbursement determined by Healthcare Resource Groups (HRGs) and national tariffs rather than historical budgets. PbR turned clinical coding into currency — the more activity a trust delivered, the more it was paid.

PbR relied on a precise scientific foundation:

ICD-10 diagnosis codes and OPCS-4 procedure codes classified each episode.
The HRG Grouper algorithm assigned a case-mix-adjusted group reflecting clinical complexity and expected resource use.
Annual Reference Cost Collections produced cost weights and base prices.

For a decade, PbR dominated English hospital finance. Yet by the late 2010s it had become clear that a purely activity-driven system could encourage over-activity and fragmentation rather than integrated, patient-centred care.

From PbR to the NHS Payment Scheme

From 2021 onwards, NHS England and the Department of Health and Social Care replaced PbR with the NHS Payment Scheme (NHSPS) — the new legal and operational framework for pricing across the NHS in England.

Feature	Payment by Results (2004–2020)	NHS Payment Scheme (2021 – present)
Payment basis	100% activity-based	Blended: fixed + variable + outcome elements
Currency	HRG tariff per episode	HRG-based currencies plus local variants
Scope	Mainly acute hospital care	Acute, community, mental health, digital care
Governance	DH → Monitor / NHS Improvement	Joint DHSC + NHS England
Aim	Drive efficiency & throughput	Balance efficiency, quality & integration

Under this new model, providers receive a fixed payment for baseline capacity, a variable payment linked to activity (still derived from HRGs), and, in some pathways, quality-linked incentives such as CQUIN or Best-Practice Tariffs.

The DNA Lives On

Although “PbR” has vanished from policy language, its scientific architecture remains central.

The National Casemix Office still updates HRG definitions annually.
National Cost Collections still underpin tariff calibration.
Grouper algorithms still translate clinical coding into costed activity.

In essence, the NHS Payment Scheme is PbR 2.0 – more integrated and more flexible but powered by the same HRG-based science that transformed healthcare economics two decades ago.

Scotland, Wales and Northern Ireland: Divergent Systems and Shared DNA

Four Nations, Four Funding Philosophies

Although the United Kingdom’s four health services share a common ancestry, their reimbursement systems diverged sharply after devolution. While England pursued an explicit Payment by Results model with HRGs and national tariffs, Scotland, Wales, and Northern Ireland retained a tradition of block-budgeting and negotiated allocations, preferring local discretion to centralised price signals.

These differences reflect not only political philosophy but also scale and administrative reality. England’s population exceeds 56 million, and its hospital network demands algorithmic precision; the devolved systems serve smaller populations and favour simpler budgeting mechanisms that support integrated planning rather than activity-driven incentives.

Scotland – Population Health over Tariffs

NHS Scotland does not operate an HRG-based tariff system. Instead, it allocates budgets to 14 regional Health Boards through a Resource Allocation Formula (NRAC) that accounts for population size, age structure, morbidity and rurality. Hospitals and community services are funded via block contracts, meaning income is largely fixed regardless of day-to-day activity.

However, Scotland still employs HRG and OPCS methodologies for cost benchmarking and comparative analysis. The Scottish Cost Book uses a modified HRG framework (known as Scottish Cost Groupings) to measure efficiency and inform the government’s medium-term financial planning.

Recent initiatives, such as Activity-Based Costing (ABC) pilots and the Patient-Level Information and Costing System (PLICS), mirror England’s analytical sophistication while preserving Scotland’s population-health ethos. The result is a hybrid model: HRG science without HRG tariffs, providing visibility of resource use but not driving provider competition.

Wales – Bridging Activity and Accountability

NHS Wales occupies the middle ground. Since 2009, Wales has dismantled its internal market but retained a strong focus on service-line costing. Funding flows from the Welsh Government to seven Health Boards through the Health Resource Allocation Formula (HRAF), supplemented by ring-fenced programme budgets.

Within hospitals, Wales uses HRG4+ groupers for internal cost reporting and quality benchmarking against English reference costs. The Finance Delivery Unit (FDU) and NHS Shared Services Partnership maintain datasets that map activity to HRGs even though there is no national tariff. This enables Wales to track efficiency, measure case mix, and engage with All-Wales Performance Frameworks linking financial data to patient outcomes.

The Welsh system is therefore data-rich but price-quiet: HRGs remain analytical tools, not payment instruments. Reforms under A Healthier Wales (2023) emphasise integration, outcomes, and value-based healthcare — aligning reimbursement more closely with population benefit than with raw activity.

Northern Ireland – Integrated Care, Shadow Pricing

Health and Social Care (Northern Ireland) combines hospital, community, and social care under a single umbrella, funded directly by the Department of Health through regional commissioning plans. Trusts operate under block allocations tied to service-level agreements with commissioners.

Since 2010, Northern Ireland has maintained shadow HRG pricing models to estimate relative efficiency and align internal reporting with English reference costs. The Health and Social Care Board (HSCB) and Information and Analysis Directorate periodically apply the English HRG Grouper to local datasets to monitor cost per case and performance variation. Yet, crucially, this remains non-transactional — no money changes hands by HRG, but the insights inform resource planning and cross-border benchmarking.

The integration of health and social services gives Northern Ireland a unique lens: it treats HRG methodology as a diagnostic tool for system performance, not a mechanism for cash transfer.

Shared Scientific DNA

Despite policy divergence, all four nations depend on the scientific underpinnings of HRG methodology:

Clinical Coding: ICD-10 and OPCS-4 remain standard across the UK, ensuring comparable activity data.
Casemix Analysis: Each nation uses HRG groupers or derivatives for performance, audit, and benchmarking.
Costing Science: Reference-cost collection, PLICS, and activity-based costing models draw from the same analytical lineage.
Policy Feedback: Findings from English PbR experiments have informed devolved reforms, shaping value-based and integrated-care funding models.

This shared infrastructure forms the UK’s health-economic genome — the statistical foundation that allows governments to model cost, complexity, and efficiency even without tariffs.

Why the Divergence Matters

The four-nation comparison underscores a central truth: there is no single best way to fund universal healthcare. England’s tariff-based model promotes transparency and productivity but risks fragmentation; Scotland’s block funding supports integration but limits financial signals; Wales and Northern Ireland balance both approaches using HRG data as a mirror rather than a lever.

For innovators in diagnostics, medtech, and digital health, understanding these nuances is critical. Market access strategies must adapt to each nation’s funding DNA: England rewards quantifiable efficiency, Scotland demands population-level evidence, Wales values system outcomes, and Northern Ireland prizes cross-sector integration.

How HRGs and Tariffs Are Updated: Governance, Evidence, and Innovation

1. The Science Behind HRG Maintenance

At the heart of England’s reimbursement architecture is the National Casemix Office (NCO), a specialised scientific unit within NHS England. Its role is to maintain the taxonomic precision of HRGs—the algorithmic “species” that convert patient-level data into reimbursable units of care.

Each HRG is defined by a set of clinical, procedural, and demographic variables. The NCO continuously analyses millions of finished consultant episodes submitted through the Secondary Uses Service (SUS) to detect statistical drift—changes in treatment patterns, case-mix complexity, or resource consumption that could distort tariff fairness.

When deviations exceed predefined variance thresholds, HRGs are resplit, merged, or reweighted. This process is underpinned by generalised linear modelling and multivariate cost regression, ensuring that differences in cost are explained by clinically meaningful factors rather than artefacts of coding practice.

2. From Raw Data to Tariff: The Economic Mechanics

The translation of clinical activity into a tariff follows a reproducible, evidence-based pipeline:

Data Capture – Hospitals submit patient-level costs via the National Cost Collection (NCC), including direct and indirect expenditure by HRG code.
Validation – NHS England applies cost-outlier detection and reconciles data against activity counts in SUS.
Cost-Weight Derivation – For each HRG, the NCO calculates a mean cost per case, standardised to remove regional inflation and outlier bias.
Tariff Calibration – The Department of Health and Social Care (DHSC) and NHS England then agree on a base price (e.g., £4,000 = weight 1.00). Each HRG’s relative cost is expressed as a cost-weight multiplier of this base.
Adjustment Factors – Tariffs are adjusted by the Market Forces Factor (MFF) to reflect local wage and estate cost variation, plus modifiers for best practice, readmission penalties, and specialist top-ups.
Publication – Final prices appear in the NHS Payment Scheme Tariff Workbook, accompanied by the year’s HRG4+ Grouper version.

This pipeline is a live example of applied health-economic modelling: cost data → regression weights → tariff outputs → behavioural incentives → new cost data, completing a feedback loop of evidence and efficiency.

3. Updating Clinical Classifications

Every two to three years, HRG updates coincide with releases of ICD-10 and OPCS-4 revisions managed by the Clinical Classifications Service. For example, OPCS-4.11 (effective 2026) introduces over 600 new subcategories reflecting minimally invasive and robotic procedures, molecular diagnostics, and advanced imaging.

These new codes are not cosmetic—they are the genetic mutations of the reimbursement genome. Without them, innovations cannot be properly recognised or priced. The NCO performs impact modelling to estimate how new codes will remap patient episodes and rebalance expenditures across trusts, ensuring fiscal neutrality while capturing technological progress.

4. Economic Governance and Consultation https://odelletechnology.com/the-role-of-the-national-casemix-office-in-nhs-coding-and-resource-management/

Tariff setting follows a formal consult-model-review-approve cycle:

Modelling Phase (April–October): NCO and NHS England model potential tariff scenarios using the latest cost data and projected activity volumes.
Engagement (November–December): Draft proposals are circulated to trust CFOs, commissioners, and professional bodies via the NHS Payment Scheme Consultation.
Approval (January–March): Final tariffs are agreed jointly by DHSC Ministers and the NHS England Board, then enacted under the Health and Care Act 2022.

This rigorous governance ensures that HRG science remains democratically accountable yet empirically grounded—a balance between political legitimacy and econometric objectivity.

5. Innovation and Evidence Translation https://odelletechnology.com/conditional-reimbursement-evidence-generation-in-europe-odelle-technology/

New technologies, diagnostics, or digital platforms can enter the tariff system through several scientific-economic gateways:

Pathway	Mechanism	Purpose
Innovation Tariffs / Top-Ups	Temporary uplift for proven innovations	Bridge gap until full HRG inclusion
Best Practice Tariffs (BPTs)	Incentivise adherence to evidence-based protocols	Reward quality and outcomes
NICE Technology Appraisals	Formal cost-effectiveness assessment (ICER ≤ £20–30 k per QALY)	Determine eligibility for national funding
Specialised Services Pathway	HRG variants with separate pricing	Support low-volume, high-cost interventions
Local Blended Payments	Negotiated mix of fixed and variable elements	Enable pilots, virtual wards, digital therapeutics

Each mechanism relies on quantitative health-economic evidence: incremental cost-effectiveness ratios (ICERs), budget-impact analyses (BIA), and real-world evidence (RWE). For example, when NICE evaluates a new diagnostic, its estimated cost per episode is mapped to an existing or provisional HRG; if the differential is material, NHS England commissions a casemix recalibration study to adjust tariffs accordingly.

6. The Innovation Feedback Loop

The modern NHS Payment Scheme has transformed HRG science into a learning system. Emerging data from Patient-Level Information and Costing Systems (PLICS), EHR integration, and machine-learning-based cost prediction feed back into annual tariff design. This enables dynamic pricing—the continuous refinement of cost weights in near real time.

The future will likely include:

Predictive cost modelling using machine learning to forecast resource use;
Outcome-linked pricing integrating HRG tariffs with PROMs and quality metrics;
Automated coding validation via AI to reduce HRG drift.

These advances reinforce the NHS’s position as a global leader in applied health-economic informatics—a system where reimbursement is not static accounting but a living experiment in data-driven efficiency.

7. Why the Update Process Matters

The precision of HRG updates determines not only financial fairness but also the adoption trajectory of medical innovation. If cost weights lag behind technology, hospitals face disincentives to adopt superior interventions; if tariffs overcompensate for obsolete procedures, inefficiency persists. The NCO’s statistical recalibration therefore functions as both a fiscal thermostat and a policy accelerometer, aligning economic signals with clinical progress.

In Summary

The machinery of NHS reimbursement operates like a scientific ecosystem:

Data Collection → Cost Modelling → Tariff Publication → Behavioural Response → Data Feedback.
Governance is shared between NHS England, DHSC, and specialist agencies such as NICE and the Office for Health Economics (OHE).
Its objective is not merely to pay bills but to sustain a self-correcting, evidence-based economy of care.

Challenges, Drift, and the Future of HRG-Based Funding

1. The Unintended Consequences of Precision

The early promise of Payment by Results (PbR) was transparency: link payment to activity, and efficiency will follow. Yet, the greater the precision of a reimbursement system, the greater its vulnerability to behavioural distortion.
In economic terms, PbR created a principal–agent problem: clinicians and coders (agents) responding to tariff incentives could alter data capture without altering care delivery, a phenomenon the BMJ (Rogers et al., 2005) famously described as “HRG drift”.

Empirically, HRG drift manifests as:

Up-coding: recording additional comorbidities or procedural complexity to move cases into higher-tariff groups;
Fragmentation: unbundling episodes into multiple billable HRGs;
Short-stay inflation: reclassifying day cases as admissions.

While some drift reflects genuine case-mix change, its cumulative fiscal effect can distort national cost weights and inflate tariffs. The health-economic outcome is tariff inflation without productivity gain, a hidden erosion of allocative efficiency.

2. Coding Accuracy: The Achilles Heel

The scientific elegance of HRG modelling depends entirely on the fidelity of clinical coding. The UK’s Clinical Classifications Service (CCS) mandates the use of ICD-10 and OPCS-4, but accuracy varies widely across trusts. Audits by NHS England routinely identify 5–15% misclassification, sufficient to shift millions in revenue.

Coding precision is shaped by three variables:

Data quality: completeness of clinician documentation.
Coder expertise: continuous training on complex procedural hierarchies.
System design: how EHR interfaces capture structured data.

To mitigate error, the NHS increasingly deploys AI-assisted coders, automated Grouper validation tools, and probabilistic record linkage to flag anomalies between clinical narratives and assigned HRGs. This fusion of informatics and economics represents the frontier of computational reimbursement science.

3. Tariff Lag and Technological Innovation

A recurring structural issue is the temporal lag between clinical innovation and tariff recognition. When new procedures, diagnostics, or digital pathways appear faster than HRG updates, they enter a reimbursement vacuum: hospitals provide advanced care but receive payment mapped to outdated comparators.

Health-economic modelling shows that even a two-year tariff lag can depress adoption by 30–40%, especially for capital-intensive or laboratory-based technologies. Interim solutions such as innovation tariffs, high-cost device exclusions, or commissioning through evaluation schemes aim to bridge this gap, but coverage remains selective. The long-term challenge is to build real-time cost learning so tariffs evolve at the speed of innovation.

4. Geographic and Structural Inequities

Despite a unified coding standard, the Market Forces Factor (MFF) and historic cost differentials still generate geographic payment variation. Hospitals in high-cost regions (London, South East) receive uplifts that may not fully reflect modern digital or workforce realities, while smaller rural trusts often operate below cost. From a welfare-economics perspective, the system risks allocative inequity — tariffs are equal across populations with unequal input prices.

Emerging reforms under the NHS Payment Scheme 2025–2026 propose dynamic MFF recalibration using provider-level PLICS data and real-time wage indices, a statistically robust move towards horizontal equity.

5. The Rise of Value-Based and Outcome-Linked Payment

Global health-economics trends are reshaping England’s tariff DNA. The future lies not merely in paying for activity but in paying for value. Several pilot models already integrate HRGs with Patient-Reported Outcome Measures (PROMs), Quality Adjusted Life Years (QALYs), and avoidable readmission metrics.

Mathematically, these models extend the HRG cost function C = f (resources) to C = f (resources, outcomes), converting tariffs into value functions. When outcome data are credible, commissioners can adjust prices using incremental net benefit (INB) calculations, aligning reimbursement with both cost-effectiveness and patient benefit.

For example, Best Practice Tariffs in orthopaedics and stroke services already reward adherence to NICE guidelines, effectively embedding QALY logic into routine payment.

6. Digital Health, AI, and the Next Frontier

The next decade will see digital therapeutics, AI diagnostics, and remote monitoring challenging traditional episode-based economics. These interventions defy HRG logic because they generate continuous, longitudinal data rather than discrete episodes.

NHS England is experimenting with “digital currencies” under the Payment Scheme, combining per-user fixed payments with performance-linked outcome bonuses — a design resembling the US Remote Physiologic Monitoring codes. Integration of HRG logic with FHIR-based data feeds, machine-learning cost models, and API-driven payment orchestration could make the NHS a testbed for algorithmic reimbursement.

7. Towards a Unified UK Casemix Future

Although Scotland, Wales, and Northern Ireland avoid tariff payments, all four nations increasingly rely on HRG data for comparative effectiveness and system planning. A cross-UK Casemix Harmonisation Forum now explores shared standards for cost collection, enabling interoperable health-economic datasets. The ultimate vision is a pan-UK cost-per-case framework, combining England’s economic precision with the devolved nations’ emphasis on population value.

8. The Scientific Horizon

In pure scientific terms, HRG-based funding is entering its post-industrial phase:

Econometric drift detection will replace manual audits.
Dynamic Bayesian updating will refresh tariffs quarterly using streaming cost data.
Digital twin models will simulate the budget impact of guideline changes before implementation.

The NHS is thus evolving from a reactive payer to a real-time learning system — a living health-economic experiment where tariffs, outcomes, and innovation form a continuously self-optimising triad.

The HRG framework began as a managerial tool but has matured into a scientific instrument of national health economics. Its future depends on the same principles that built it: rigorous data, statistical transparency, and clinical integrity. As coding becomes digital, tariffs become adaptive, and outcomes become measurable, the machinery of NHS funding may finally achieve what it promised two decades ago — to make every pound follow genuine value, not volume.

How coding turns into money: step-by-step (England)

1) The clinician documents the care.
Discharge summaries/operation notes capture diagnoses, procedures, comorbidities, devices, length of stay, critical care, etc. Accurate, specific documentation is the start of everything downstream. (General SUS/PbR overview). NHS England Digital

2) Clinical coders assign ICD-10 (diagnoses) and OPCS-4 (procedures).
OPCS-4 translates procedures into alphanumeric codes; ICD-10 does the same for diagnoses. These are the only inputs the Grouper will “understand”, so specificity matters (laterality, approach, devices, complexity).

3) Episodes and spells are built.
A patient may have multiple FCEs (consultant episodes) within a spell (continuous stay). HRG4+/NHS Payment Scheme generally uses spell-based HRGs for admitted care, so the combination across the spell drives the main HRG.

4) The HRG Grouper runs.
NHS England’s HRG4+ Grouper ingests CDS/SUS extracts and assigns:

Core spell HRG (main currency),
Episode HRGs (for analysis),
Unbundled HRGs for specific activities (e.g., critical care, chemo, dialysis, high-cost imaging), often triggered by specific OPCS-4 codes and hierarchy rules.

5) Procedure hierarchy & diagnosis fallback.
Each OPCS-4 code has a hierarchy value (resource signal). If no qualifying procedure is present, grouping “flips” to diagnosis-driven logic. This explains why omitting a key procedure code can drop the HRG.

6) Prices/tariffs apply.
The NHS Payment Scheme uses HRG currencies within blended payments (fixed + variable) and other mechanisms. HRG cost weights derive from the National Cost Collection; local prices then adjust for market forces. Factor and policy add-ons.

The relationship: OPCS-4/ICD-10 → HRG → tariff

The Scientific Core: From Clinical Facts to Economic Signals

ICD-10 + OPCS-4 = Clinical “Facts”

At its most fundamental level, the NHS reimbursement model rests on two global classification systems that encode the patient’s journey as structured data:

System	Function	Type of Information Captured	Scientific Foundation
ICD-10 (International Classification of Diseases, 10th Revision)	Describes why the patient was treated	Diseases, injuries, and comorbidities	Developed by WHO for epidemiological surveillance and mortality statistics; based on nosology and pathophysiology
OPCS-4 (Office of Population Censuses and Surveys Classification of Surgical Operations and Procedures)	Describes what was done	Surgical, diagnostic, or therapeutic procedures	Developed by NHS England’s Clinical Classifications Service; updated with every new medical technique

Each episode of care produces a matrix of diagnosis codes (ICD-10) and procedure codes (OPCS-4).
These codes are the atomic units of clinical reality: they transform narrative notes into quantifiable data suitable for statistical and economic modelling.

Scientifically, this transformation is vital because it enables:

Standardisation: Different hospitals, clinicians, and systems describe care in the same vocabulary.
Computational inference: Algorithms can infer complexity, risk, and expected cost from patterns in the codes.
Epidemiological linkage: The same codes underpin surveillance, outcomes research, and resource allocation.

Without these codes, the NHS cannot measure what it delivers — let alone fund it.

The HRG Grouper = Translating Biology and Activity into Resource Models

The HRG Grouper is a deterministic algorithm maintained by the National Casemix Office (NHS England).
It analyses the ICD-10 and OPCS-4 combinations from each spell (continuous period of care) and assigns an HRG (Healthcare Resource Group) — a cluster of cases statistically proven to consume similar resources.

Mechanics of Grouping

Input: Diagnosis (ICD-10), procedures (OPCS-4), age, sex, comorbidities, discharge status, length of stay.
Hierarchical Logic:
- Procedure hierarchy identifies the dominant resource-driving procedure.
- If none qualifies, diagnosis becomes the driver (medical HRG).
Complexity Splits: Statistical regressions on national cost data determine whether secondary diagnoses (e.g., major complications/comorbidities) justify a higher-complexity subgroup (A, B, or C suffixes).
Output: A unique HRG code (e.g., EA31Z = “Coronary Artery Bypass Graft with CC”) representing an empirically derived resource signature.

Scientific Rationale

Derived from multivariate cost-function modelling: cost = f(diagnosis, procedure, LOS, age, comorbidity).
The method ensures case mix adjustment, allowing for a fair comparison of hospitals in terms of efficiency and outcomes.
Provides the currency unit linking clinical work to economics.

Essentially, the Grouper performs the computational physiology of finance: it predicts, from coded biology and activity, how much resource a case will require.

NHS Payment Scheme = Converting HRGs into Currencies and Prices

Once grouped, HRGs feed into the NHS Payment Scheme — the economic layer that turns clinical reality into monetary flow.

Step 1 – Cost Estimation:
Each HRG has an empirically observed mean cost from the National Cost Collection, built from patient-level costing (PLICS) across all providers.

Step 2 – Weighting:
Those mean costs are converted into relative cost weights — e.g., HRG X = 1.25 × base cost, HRG Y = 0.75 × base cost.

Step 3 – Pricing:
A base price (say £4 000) is applied to all HRGs, then multiplied by the weight.
Additional adjustment coefficients model geography (market forces factor), teaching status, and best-practice incentives.

Step 4 – Contracting:
Prices become “currencies” inside blended payment models (fixed + variable + outcome elements) implemented via digital APIs between trusts, ICBs, and NHS England.

Why This Chain Is Scientifically and Economically Critical

Dimension	Scientific Importance	Economic/Policy Impact
Data Integrity	Coding systems create reproducible observations of clinical events.	Enables evidence-based funding and national performance benchmarking.
Causal Inference	HRG algorithms model resource use as a function of pathology and procedure.	Supports cost-effectiveness analysis, HTA inputs, and tariff fairness.
Statistical Equity	Casemix adjustment removes bias from hospital comparisons.	Drives allocative efficiency and transparent reimbursement.
System Learning	Continuous data feedback allows econometric recalibration.	Tariffs evolve with real-world costs — preventing drift and underpayment.

If any link breaks — inaccurate coding, flawed grouping, or outdated tariffs — the entire system’s health-economic equilibrium collapses.
Hospitals would be rewarded for volume without value; national cost data would distort; and policy decisions (e.g., NICE budget-impact estimates) would lose validity.

ICD-10 + OPCS-4 = clinical “facts”.
Grouper is an algorithm that maps those facts to HRGs (resource-similar groups).
NHS Payment Scheme = turns HRGs into currencies/prices inside modern contracting (API/blended payments).

ICD-10 + OPCS-4 record the clinical truth, the HRG Grouper interprets that truth in economic terms, and the NHS Payment Scheme turns it into actionable funding.
Together they create one of the world’s most sophisticated examples of applied health-economic informatics — the machinery that keeps clinical reality and financial reality in constant, measurable alignment.

The Hidden Mathematics of Fairness

From an econometric standpoint, the NHS reimbursement model is a multi-level hierarchical regression system in which: Costij=β0+β1(Diagnosisij)+β2(Procedureij)+β3(Comorbidityij)+uj+ϵij \text{Cost}_{ij} = \beta_0 + \beta_1(\text{Diagnosis}_{ij}) + \beta_2(\text{Procedure}_{ij}) + \beta_3(\text{Comorbidity}_{ij}) + u_j + \epsilon_{ij} Costij=β0+β1(Diagnosisij)+β2(Procedureij)+β3(Comorbidityij)+uj+ϵij

where i = patient, j = hospital, and u_j represents provider-level random effects (efficiency).
The HRG is a categorical simplification of this regression space: each group defines an approximate iso-cost contour.
This makes HRGs both statistically efficient (parsimonious) and administratively usable (one code → one price).

How to request a new OPCS-4 code (or change one)

If a new procedure or approach isn’t adequately represented:

Check existing OPCS-4 (and Clinical Coding Standards) to avoid duplication.
Submit a change request via the OPCS-4 Request Submission Portal (NHS England Clinical Classifications Service). Provide clinical rationale, evidence of usage, distinctions from existing codes, and expected impact.
Timeline & governance. Requests are accepted year-round; NHS England batches/evaluates them for the next release (e.g., OPCS-4.11 effective April 2026 after a July 2025 consultation; 747 change requests evaluated).
Publication. If approved, the change appears in the next OPCS release & standards manual; the NCO models HRG impact in the next Grouper cycle.

Wales signposts change requests to the same NHS England portal; devolved nations align with the classification baseline.

How to influence HRG design (when codes exist but grouping is sub-optimal)

Use the Consultation/Local Payment Grouper to test how cases map and gather evidence of mis-grouping or resource mismatch. Submit feedback during the NCO consultation window.
Anchor proposals to currency principles in the Payment Scheme (clinically meaningful, analytically identifiable, and practical to implement). Provide cost data (PLICS/NCC), volumes, and clinical pathways.
Track annual HRG4+ Local Payment Grouper releases and Summary of Changes to see where your pathway may be picked up by revised logic/unbundling.

How to analyse an HRG in your own data (practical playbook)

A) Prepare data (month/quarter).

Extract CDS/SUS-like fields: NHS number (or pseudo), DOB/age, sex, admission/discharge dates, spell ID, FCE IDs, ICD-10s, OPCS-4s (with dates & laterality), consultant/TFC, LOS, theatre time, and ICU flags.
Pre-process exclusions (e.g., Treatment Function Code filters) as per the Grouper manual.

B) Run the Grouper locally.

Use the HRG4+ Local Payment Grouper with the correct year version; generate spell HRGs, episode HRGs, and unbundled HRGs. Keep a version audit trail.

C) Build an HRG dashboard (minimum set).

Volume by HRG; case-mix index; unbundled HRG counts (e.g., CCU, dialysis); average cost vs reference (if you hold PLICS).
Outlier bands: LOS, theatre minutes, high-cost drugs/devices.
Coding completeness: % episodes with primary procedure, % with major CC, diagnosis–procedure concordance.

D) Compare with national materials.

Sense-check grouping behaviour against the Grouper User Manual and any Summary of Changes notes. If your procedure should trigger an unbundled HRG but doesn’t, investigate coding dates, laterality, or missing ancillary codes.

E) Link to finance.

Apply 2025/26 NHS Payment Scheme rules (variable vs fixed elements) to estimate revenue sensitivity to coding improvements or pathway redesign. Use Annexe B (Currencies) to ensure your “unit” makes clinical and analytical sense.

F) Quality & audit.

Sample audit notes vs codes; train coders on procedure hierarchy pitfalls; rerun the Grouper after corrections to quantify “HRG drift” effects and potential revenue at risk.

Common pitfalls (and quick fixes)

Forgetting unbundled components. Unbundled HRGs (e.g., critical care) pay for many high-value activities. Ensure the triggering OPCS/clinical indicators are present and correctly dated.
Episode vs. spell confusion. Don’t group twice—use the spelling HRG as the main currency; exclusions are at the spelling level.
Mismatches between the old grouper and the version should also be addressed. Always align the coding year, Grouper version, and payment scheme year; logic changes year to year.
Weak currency definitions in local pilots. If you’re building a local/digital currency, check the Annexe B criteria (clinically meaningful, analytically identifiable, practical).

How to Get a New Procedure Recognised in the NHS

Code – Define the Procedure (NHS England – Clinical Classifications Service)
First, check whether an existing OPCS-4 code already captures your intervention.

Search the latest OPCS-4 manual and NHS Digital ClassBrowser for a precise match.
If no suitable code exists, submit a new code request via the OPCS-4 Request Submission Portal at NHS England Digital.
Your submission must include:
- A clear clinical description and rationale;
- Peer-reviewed or trial evidence demonstrating distinct technique or purpose;
- Estimated case volumes and clinical users;
- Distinction from existing codes to avoid duplication.
  Approved codes are incorporated into the next OPCS-4 release (e.g., 4.11 → April 2026) following national consultation.

Group – Align with HRG Logic (National Casemix Office, NHS England)
Once coded, the procedure must fit within the HRG4+ Grouper logic that converts coded activity into billable Healthcare Resource Groups.

During the annual National Casemix Office (NCO) consultation, present resource-use evidence—for example:
- Average Patient-Level Information and Costing System (PLICS) data;
- Operating-theatre time and consumables;
- ICU admission probability or postoperative care load.
Demonstrating a material resource difference allows the NCO to assign your procedure to an appropriate existing HRG, create a new HRG split, or flag it as an unbundled HRG (for chemotherapy, critical care, dialysis, etc.).
This step ensures the activity is not only coded but also scientifically mapped to a recognised cost group.

Price – Establish Cost Evidence (NHS Payment Scheme / National Cost Collection)
Finally, the procedure must be priced.

Submit robust costing through your trust’s National Cost Collection submission or provide detailed local data to NHS England’s pricing team.
Cost evidence should show direct and indirect components—staff time, consumables, capital depreciation, and overheads—aligned with PLICS methodology.
These costs are modelled into the HRG reference-cost dataset, underpinning tariff calibration under the NHS Payment Scheme.
When sufficient cost and volume data accumulate, the intervention becomes eligible for a national tariff or local blended-payment currency.

In Summary:
→ Code it. → Group it. → Price it.
Every recognised NHS procedure passes through this three-stage pipeline, from classification (OPCS-4) → grouping (HRG) → valuation (tariff).
Understanding and evidencing each step ensures new techniques, devices, or diagnostics can move from clinical innovation to formal NHS reimbursement.

Conclusion & Policy Outlook: Digital Evolution, AI, and the Future of Control

1. The Digital Transformation of Reimbursement

The NHS is undergoing a fundamental shift from a retrospective, manually coded payment model to a digitally synchronised reimbursement ecosystem. Electronic health records, structured data standards (FHIR, SNOMED CT), and AI-driven automation are beginning to close the lag between clinical activity and financial settlement.

Under the modern NHS Payment Scheme, every episode, procedure, or diagnostic pathway generates a digital footprint that can be validated, grouped, and priced in near-real time.
This continuous data capture forms the basis of what economists now call the “live tariff environment”—a feedback loop where cost, quality, and outcomes evolve together.

2. AI and the Rise of Computational Coding

The Clinical Classifications Service within NHS England Digital is piloting natural-language-processing (NLP) systems that parse operation notes and discharge summaries to auto-suggest ICD-10 and OPCS-4 codes.
Machine-learning models trained on millions of Secondary Uses Service (SUS) episodes are now capable of predicting the most likely HRG assignment and flagging anomalies.

Key developments include:

AI-assisted coding engines integrated into hospital EPRs (Epic, Cerner Millennium, Allscripts).
Automated HRG validation tools that detect improbable code combinations and prevent “drift” before submission.
Predictive cost models combining length-of-stay, device use, and comorbidity clusters to forecast tariff impact.

These tools are transforming clinical coding from a clerical function into a computational science of reimbursement, strengthening both financial accuracy and data quality.

3. Who Actually Controls the System

Control is distributed but coordinated through a clear scientific-regulatory hierarchy:

Entity	Core Responsibility	Scientific/Policy Levers
Department of Health and Social Care (DHSC)	Sets national payment policy and approves final prices under the Health and Care Act 2022	Policy direction, statutory authority
NHS England – Pricing & Incentives Team	Designs the NHS Payment Scheme and oversees tariff modelling, consultations, and publication	Economic modelling, blended-payment design
National Casemix Office (NCO)	Develops and maintains HRGs and Grouper logic	Statistical grouping algorithms, case-mix analysis
Clinical Classifications Service (CCS)	Maintains OPCS-4 and ICD-10 coding standards	Clinical taxonomy and coding governance
NHS England Digital / Data Services Platform	Hosts the Secondary Uses Service (SUS) and national cost datasets	Data infrastructure, validation, automation
NICE & Office for Health Economics (OHE)	Provide economic evaluation and cost-effectiveness frameworks	ICER, QALY, and health-economic standards
Audit & Regulatory Bodies (NAO, CQC)	Monitor system integrity and detect gaming or drift	Oversight and compliance

Together these organisations maintain a technocratic equilibrium: clinicians supply data, coders translate it, economists weigh it, and digital systems enforce it.

4. Digital Convergence Across the UK

Although only England operates a tariffed HRG system, the devolved nations are converging digitally.
Scotland’s Patient Level Costing Programme, Wales’s Finance Delivery Unit, and Northern Ireland’s Integrated Care Analytics Hub all use compatible data standards and HRG-based cost benchmarking.
By 2030, interoperability through UK-wide FHIR APIs will likely permit comparative cost-per-case dashboards across all four health services — a technical step towards a pan-UK evidence economy.

5. Health-Economic Implications of Automation

AI-enabled reimbursement is expected to alter the economics of healthcare financing in three measurable ways:

Reduced transaction costs: real-time validation will cut the administrative cost of payment processing by up to 40%.
Improved allocative efficiency: automated grouping and anomaly detection will minimise HRG drift and mis-tariffing.
Dynamic pricing: with continuous cost data, the base tariff can be updated quarterly using Bayesian econometric models, aligning incentives with actual practice faster than annual updates.

For health economists, this transforms tariff modelling into a living Bayesian system—a perpetual calibration between predicted and observed costs.

6. Risks and Safeguards

Automation brings its own hazards:

Algorithmic bias could propagate historic coding inequities (e.g., under-recorded comorbidities in deprived populations).
Overfitting could destabilise tariffs if models chase noise rather than true resource changes.
Hence, governance frameworks now mandate:
Human-in-the-loop validation for AI-generated codes;
Audit transparency under NHS England’s Data Ethics Framework;
Annual independent econometric review of tariff algorithms by the OHE.

7. The Policy Horizon

By 2027–2030, expect three systemic evolutions:

Real-Time Tariff Engine: HRG weights are recalculated continuously using live SUS feeds.
Outcome-Linked Currencies: tariffs modulated by PROMs, readmission rates, and AI-predicted recovery trajectories.
Unified Data-Economy Governance: a cross-UK Digital Reimbursement Council harmonising coding, AI standards, and cost transparency.

These reforms position the UK to pioneer evidence-responsive reimbursement, integrating data science, economics, and policy in a single adaptive system.

8. In Closing

The NHS’s reimbursement architecture began as a mechanical ledger of care but is evolving into an AI-enhanced scientific ecosystem.
Each HRG now embodies not only cost but data lineage; each tariff represents a probabilistic estimate of value.
Control no longer resides in any single office but in a network of algorithms, economists, and policy custodians whose shared mission is to sustain equitable, data-driven healthcare.

In the coming decade, the real question will not be how the NHS pays for care but how intelligently, transparently, and fairly those payments learn from every patient treated.

FAQs: coding errors, HRG drift & MedTech

1) What exactly is “HRG drift”, and how is it different from simple coding error?
HRG drift is a systematic shift in the case-mix toward higher-paying HRGs over time that cannot be fully explained by genuine clinical complexity. A coding error is a random or mistaken misclassification. Drift can arise from documentation emphasis (e.g., comorbidities) or coding selection habits—even when each individual code seems defensible.

2) Which of the three coding defects most commonly distort HRG assignments?
a) Missing primary procedure (OPCS-4) or wrong laterality/approach; b) Under-recorded CC/MCC diagnoses (ICD-10) that change complexity splits; c) Dates out of sequence (procedure after discharge) that break unbundled triggers (e.g., critical care).

3) How do “unbundled HRGs” become missed—and what does that cost?
Unbundled HRGs (e.g., adult critical care, chemo, dialysis, high-cost imaging) are triggered by specific codes/indicators. If triggers are absent or misdated, the spell is paid without the unbundled component. For high-acuity services this can mean £100s–£1,000s per spell lost.

4) Why should a MedTech company care about OPCS-4 and ICD-10 minutiae?
Without a code, there would be no case, no price, and no evidence. If your procedure or device use isn’t unambiguously codable, hospitals struggle to recover costs, slowing adoption and obscuring your clinical/economic value in real-world data.

5) What are early warning signs of HRG drift on a hospital dashboard?

Rising case-mix index without matching LOS, theatre time, and ICU rates.
Upward shift in complexity suffixes (A/B) across the same speciality.
Increased data queries/validation flags from the SUS submission.
There is a significant difference in the cost per case of PLICS compared to the national reference cost.

6) How can missed comorbidities change the HRG—and when is it legitimate?
Under-recorded ICD-10 CC/MCC can push cases into lower-complexity HRGs. It’s legitimate to code clinically relevant, explicitly documented conditions that affect care. Education should focus on documentation quality, not “gaming”.

7) What’s the fastest way to spot missed unbundled HRGs for a pathway?
Run a joint audit: spell HRG + ICU days, OPCS-4 flags (e.g., chemo, dialysis), and HDU/CCDS indicators. Compare expected unbundled counts (from clinical rosters or bed states) to billed unbundled HRGs. Any >5–10% gap warrants review.

8) We’re launching a new device—what pre-market coding checks should we do?

Map indications to ICD-10 and technique to OPCS-4 (existing vs new code needed).
Test in a local payment grouper to see HRG impact.
Draft a clinical documentation template (keywords that support precise coding).
Create a one-page coder guide with valid code combinations and exclusion notes.

9) Can natural language processing (NLP) correct coding errors automatically?
NLP can suggest codes from op notes and discharge summaries, flag inconsistencies, and surface likely CCs. It should be human-in-the-loop, audited against precision/recall targets, and monitored for bias (e.g., under-documentation in deprived groups).

10) How do we quantify revenue at risk from coding defects in one quarter?
Build a variance model: (Grouped HRG ⟶ Expected £ under NHS Payment Scheme) – (Corrected HRG ⟶ Re-grouped £) across a validated sample, then extrapolate using binomial CIs. Segment by speciality, consultant, and site to target training.

11) What’s the governance line between coding quality and fraud risk?
Legitimate: complete, specific, evidence-based documentation and coding per standards.
Risky practices include patterns of upcoding that lack clinical support, post-hoc code stacking, or unusual spikes in unbundled services. Safeguard with independent audit, coder rotation, and prospective validation rules.

12) Our HRG complexity is increasing, while device usage and length of stay (LOS) remain unchanged—can you explain this?
This may be due to documentation-led drift, which results in more CCs being recorded, or it could be a result of coding selection bias. Cross-check: complexity ↑ should correlate with resource proxies (LOS, ICU rate, consumables, theatre minutes). If not, perform a focused clinical note audit.

13) Which report should MedTech request from sites to prove value?
An before/after HRG & unbundled profile with:

HRG mix, complexity suffix, LOS, ICU %, readmission %,
PLICS cost per case, consumables,
The unbundled rate and the coding query rate are often overlooked.
Combine the clinical outcomes with the data to create a value dossier.

14) What documentation phrases most help coders code a novel technique?

Approach/route (percutaneous, endovascular, robotic).
The identification of the anatomical target (vessel, segment, or side) is crucial.
The device details include information about the implant, its size, and any adjuncts used.
The clinical intent can be either diagnostic or therapeutic.
Intra-op events that justify CC/MCC diagnoses.

15) How often should a trust run “Grouper version reconciliation”?
At least annually (preferably per tariff year change). Re-group a sample of high-value spells under the new HRG Grouper to see tariff impact; update coding aids/templates accordingly.

16) What’s the cleanest KPI set for coding-quality monitoring?

% spells with unbundled HRG present when clinically indicated
Diagnosis–procedure concordance rate
CC/MCC capture rate for target pathways
HRG volatility index (month-to-month mix shift)
Coder query turnaround and audit error rate

17) How do you separate genuine case-mix change from HRG drift?
Use triangulation: (a) clinical severity markers (NEWS2, ASA, ICU rate), (b) resource markers (LOS, theatre/ICU minutes), and (c) outcome markers (complications/readmissions). If the complexity of the HRG increases without changes in either clinical severity markers (a) or resource markers (b), then it is advisable to suspect drift.

18) Our innovation reduces theatre time, but it does not affect the HRG—what should we do next?
Show within-HRG cost/throughput gains via PLICS and capacity modelling (e.g., more cases/day, shorter wait lists). Use local blended payments or best practice tariff arguments; pursue a future HRG split with NCO evidence.

19) When should we advocate for creating a new OPCS-4 code instead of reusing an existing one?
If your technique is materially distinct (approach/anatomy/intent) and changes resource use or outcomes, request a new code; otherwise, provide a coding note for existing codes to ensure consistent capture. Always check ClassBrowser/Standards first.

20) What’s a pragmatic 90-day plan to reduce coding loss for a target pathway?

Days 1–15: Baseline missed unbundled rate, CC capture, LOS, ICU%; sample audit of notes.
Days 16–45: Coder + clinician huddles; build templated op notes; quick eLearning on hierarchy pitfalls; implement NLP suggestions.
Days 46–75: Re-group retrospective cohort; reconcile PLICS vs tariff; fix systematic defects.
Days 76–90: Lock in validation rules, publish KPI dashboard, and plan quarterly QA.

Policy & Payment Framework (England)

NHS Payment Scheme 2025/26—Overview & Annexes (currencies, BPT).
NHS England (2025).
https://www.england.nhs.uk/publication/2025-26-nhs-payment-scheme/
Annex B: Guidance on Currencies (HRGs, unbundled logic, outpatient currencies).
NHS England (2025).
https://www.england.nhs.uk/long-read/25-26-nhsps-annex-b-guidance-on-currencies/
Understanding and Using the National Tariff (coding → grouping → price).
NHS England (2021).
https://www.england.nhs.uk/wp-content/uploads/2021/02/20-21NT_Understanding_and_using_the_national_tariff.pdf
The National Tariff Payment System 2020/21 encompasses the scope, pricing method, and variations.
NHS England (2021).
https://www.england.nhs.uk/wp-content/uploads/2021/02/20-21_National-Tariff-Payment-System.pdf
The document provides a Simple Guide to Payment by Results, covering topics such as history, grouping, and unbundling.
Department of Health (2013).
https://www.gov.uk/government/publications/simple-guide-to-payment-by-results

HRG & Casemix Science (National Casemix Office)

The HRG Grouping—SUS PbR Reference Manual provides spell definitions and an overview of episodes.
NHS England Digital (2025).
https://digital.nhs.uk/services/secondary-uses-service-sus/payment-by-results-guidance/sus-pbr-reference-manual/hrg-grouping
The SUS PbR Reference Manual includes definitions of currency and outlines the process flow.
NHS England Digital (2022).
https://digital.nhs.uk/services/secondary-uses-service-sus/payment-by-results-guidance/sus-pbr-reference-manual
The HRG Design Concepts and Casemix Companion includes information on splits, rules, and performance tests.
National Casemix Office (2023).
https://digital.nhs.uk/services/national-casemix-office/the-casemix-companion/hrg-design-concepts
Healthcare Resource Groups — HRG4+ (overview and evolution).
National Casemix Office (2023).
https://digital.nhs.uk/services/national-casemix-office/the-casemix-companion/healthcare-resource-groups

Clinical Classifications & Coding Standards

OPCS-4 National Clinical Coding Standards (V12.0, 2025).
NHS England – Classifications Service.
https://classbrowser.nhs.uk/ref_books/OPCS-4.10_NCCS-2025.pdf
The Clinical Classifications Service and Browser includes ICD-10 and OPCS-4 classifications.
NHS England (2025).
https://digital.nhs.uk/services/terminology-and-classifications/clinical-classifications
OPCS-4.11 (Effective April 2026)—Final Changes (consultation outcomes).
Med Tech Reimbursement Consulting (summarising NHS England releases) (2025).
https://mtrconsult.com/news/changes-opcs-procedure-coding-classification-take-effect-april-2026-england

Costing, PLICS & National Cost Collection

National Cost Collection (NCC) — method feeds for HRG cost weights.
NHS England.
https://www.england.nhs.uk/costing-in-the-nhs/national-cost-collection/
Technical Guide to Allocation Formulae & Convergence 2025–26
NHS England (2025).
https://www.england.nhs.uk/wp-content/uploads/2025/02/PRN01601-technical-guide-to-allocation-formulae-and-convergence-for-2025-to-2026-revenue-allocations.pdf

Devolved Nations (Funding Models, Benchmarking & HRG Use)

Methods, Critique & Context

PbR → NHSPS Transition

Use: Refs 1–4

“How Codes Flow to Money”

Use: Refs 3, 6–9, 10–12

Costing / Tariff Methodology

Use: Refs 1–4, 13

Devolved Nations Sections

Scotland: 15–18
Wales: 19–20
Northern Ireland: 21–23

Drift, Incentives & Risks

Payment Systems & Better Care
Appleby J, Harrison T, Hawkins L. King’s Fund (2012).
https://assets.kingsfund.org.uk/f/256914/x/a024b91a9b/payment_by_results_report_november_2012.pdf

“HRG Drift” & Payment by Results (seminal).
Rogers R, Williams S, Jarman B, Aylin P. BMJ (2005).
https://www.bmj.com/content/330/7491/563

How to secure new HRG and OPS codes in the NHS.